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way. Clinicians in these arenas, including vascular surgeons, cardi-
ologists, and interventionalists, require a basic understanding of
the state of this field and are increasingly queried by their patients
who have anecdotal information from the lay press.
That being said, this volume is primarily directed at the angio-
genesis research community. The international group of contribu-
tors is composed of basic researchers from both university and
biotechnology settings. As a summary of the proceedings of an
international symposium, the monograph provides a general update
on areas of research that is most useful to those actively engaged in
basic or translational investigations. The book is loosely organized
into seven sections: angiogenic cytokines, signal transduction mech-
anisms, matrix interactions, inhibitors of angiogenesis, angiogenesis
in neoplasia, preclinical development of angiogenesis inhibitors, and
clinical applications in ischemia. The individual chapters are nar-
rowly focused overviews of a specific area in basic angiogenesis
research. There is no attempt made at providing a broad back-
ground summary for those who are not knowledgeable in this field.
The chapters are somewhat uneven in style and length, perhaps
reflecting the nature of a multinational authorship. Perhaps the
most relevant chapter for those interested in peripheral vascular dis-
ease is “Therapeutic Angiogenesis for Ischemic Heart Disease,” in
which the basic science, preclinical studies, and the phase I/II clin-
ical trials of angiogenic therapy for coronary artery disease are nicely
summarized. Unfortunately, the peripheral vascular trials, which
have been far less numerous, are omitted.
As a practicing vascular surgeon with a basic science interest
that does not involve angiogenesis per se, I found this text too
specialized and of limited utility. It did not provide the type of
broad background information in a format that was easily
digestible to the uninitiated. I suspect that most vascular clinicians
and even clinician-scientists who are not intimately familiar with
the field of angiogenesis will also find it lacking in this regard. On
the other hand, the monograph is a potentially useful update to
the growing number of scientists who are actively engaged in
basic or clinical research in angiogenesis.
Michael S. Conte, MD
Brigham and Women’s Hospital
Boston, Mass
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Metabolic diseases and diabetic complications
F. Crepaldi, A. Triengo, S. DelPrato; 1999; Elsevier Science;
276 pages; $139.50.
This monograph represents a compilation of lectures given at
the Seventh European Symposium on Metabolism in October
1998. As the title suggests, emphasis is placed on type II diabetes
and the insulin resistance syndrome, or so-called Syndrome X,
and the associated metabolic alterations that cause a characteristic
predisposition for accelerated atherosclerosis. With an increasing
awareness and incidence of these disease entities, the book should
certainly be useful to anyone with a scientific or clinical interest in
diabetes, and many of the chapters provide useful summaries of
current research in the field. Although a wide variety of compli-
cated topics are covered, readers will appreciate the succinct chap-
ters (average 4 pages), which, for the most part, are easy to read
and understand. However, as would be expected from a textbook
compiled from a symposium focused on specific published
research topics, many of the chapters are written almost verbatim
from the original reports, and as such, the book more closely
resembles a “mega-journal” rather than a textbook.
Vascular access for hemodialysis, VII
M. L. Henry; Chicago; 2001; Bonus Books; 362 pages;
$69.95.
This hardcover book is the seventh book in a series that deals
with different aspects of hemodialysis access and offers a great
deal of information that was presented in a day-and-a-half meet-
ing devoted exclusively to issues associated with dialysis access.
The contributors of this book are from all fields that deal
with end-stage renal disease, including general and vascular
surgery, transplantation, interventional radiology, and nephrol-
ogy, with different ranges of experiences and practices.
Each of the seven sections in this book is followed by a series of
questions addressed by discussants with the response of the author
about practical aspects in managing dialysis access. I found this part
of the book very provocative, practical, and extremely helpful to the
practicing physician; it gives you the impression that you are listen-
ing to a live discussion of a scientific paper at a national conference.
Each of the 32 chapters in this book contains a brief, easily
understood presentation by an author regarding his respective
field, followed by a list of references. Several chapters contain
descriptions of the standard arteriovenous fistulae, grafts, dialysis
access catheters, and some of the new modalities that are not
often seen in the standard textbooks of vascular surgery, trans-
plantation, or nephrology, with frank discussion about their out-
come and how to deal with the complications, as well as some
new, minimally invasive methods to create arteriovenous fistulae
and appropriate pictures and drawings.
I found the chapter that addresses the CPT and ICD-9 cod-
ing for dialysis access extremely practical and a good resource for
the average practitioner to use in his or her practice.
The controversies about favoring one kind of access over the
other was presented fairly and honestly by appropriate subspecial-
ists in the field, which makes the book very appealing to all the
specialties that have to deal with end-stage renal disease; there-
fore, I find the book to be intended for use by practitioners in the
fields of general and vascular surgery, transplantation, interven-
tional radiology, and nephrology, including their residents and
nurse practitioners.
Its price of $69.95 is attractive and makes it a good buy. At
the same time, the small size of the book makes it practical to use





Angiogenesis: From the molecular to integrative
pharmacology
M. E. Maragoudakis; 2000; Kluwer; 382 pages; $95.00.
This text contains the proceedings from the “Fifth Biannual
Meeting on Angiogenesis: From the Molecular to Integrative
Pharmacology,” held July 1 through 7, 1999, on the island of
Crete, Greece. Angiogenesis is an area of enormous current
research activity, spanning basic science to the clinic, and involv-
ing a broad spectrum of scientists from academia and industry.
The speed of new discovery in this field has been astounding, with
new signaling pathways and modulators being identified monthly.
Both the suppression of angiogenesis (cancer, proliferative
retinopathy, arthritis, etc) and the enhancement of angiogenesis
(ischemic cardiovascular diseases, wound healing) have become
targets of drug development with numerous clinical trials under
